Shugeng Zhang

1.5k total citations
20 papers, 392 citations indexed

About

Shugeng Zhang is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Shugeng Zhang has authored 20 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Shugeng Zhang's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Shugeng Zhang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Shugeng Zhang collaborates with scholars based in China, Hong Kong and United States. Shugeng Zhang's co-authors include Lianxin Liu, Hongrui Guo, Shuhang Liang, Jiabei Wang, Dalong Yin, Zhaoyang Lu, Dehai Wu, Ruipeng Song, Linmao Sun and Xuan Song and has published in prestigious journals such as Cancer Research, Oncogene and Gut.

In The Last Decade

Shugeng Zhang

16 papers receiving 388 citations

Peers

Shugeng Zhang
Ryota Souzaki Japan
Sungwon Lee South Korea
Jiaxin Li China
Jingyan Tang China
Yaling Dou United States
Qi Feng China
Atsuko Fujihara Japan
Hiroto Matsuoka Japan
Sae‐Ryung Kang South Korea
Ryota Souzaki Japan
Shugeng Zhang
Citations per year, relative to Shugeng Zhang Shugeng Zhang (= 1×) peers Ryota Souzaki

Countries citing papers authored by Shugeng Zhang

Since Specialization
Citations

This map shows the geographic impact of Shugeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugeng Zhang more than expected).

Fields of papers citing papers by Shugeng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shugeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugeng Zhang. The network helps show where Shugeng Zhang may publish in the future.

Co-authorship network of co-authors of Shugeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shugeng Zhang. A scholar is included among the top collaborators of Shugeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shugeng Zhang. Shugeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Shuo, Yao Liu, Ning Zhang, et al.. (2025). Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma. Cancer Letters. 626. 217774–217774. 2 indexed citations
3.
Fang, Jun, Tielong Wang, Kang He, et al.. (2025). Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study. Gut. gutjnl–2025. 1 indexed citations
4.
Zhang, Shaobo, Zebin Zhu, Lianxin Liu, Björn Nashan, & Shugeng Zhang. (2025). Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma. Cancer Immunology Immunotherapy. 74(7). 209–209.
5.
Zhang, Shaobo, Björn Nashan, Yanli Wang, & Shugeng Zhang. (2025). Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapy. World Journal of Clinical Oncology. 16(6). 107255–107255.
6.
Wang, Ning, Zebin Zhu, Hao Zheng, et al.. (2024). Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner. Transplantation Proceedings. 56(6). 1390–1395.
7.
Meng, Fanzheng, Dalong Yin, Jiabei Wang, et al.. (2024). Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience. Therapeutic Advances in Medical Oncology. 16. 12703130–12703130. 1 indexed citations
8.
Zhu, Zebin, et al.. (2024). Liver Transplantation for Diffuse Form of Caroli Disease with Chronic Hepatitis B: A Case Report. Transplantation Proceedings. 56(5). 1161–1164. 1 indexed citations
9.
Yang, Jing, Wei Zhang, Shugeng Zhang, et al.. (2023). Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease. Aging and Disease. 14(3). 652–652. 25 indexed citations
10.
Wu, Dehai, Shuhang Liang, Hongrui Guo, et al.. (2022). Downregulation of MARC2 Promotes Immune Escape and Is Associated With Immunosuppression of Hepatocellular Carcinoma. Frontiers in Genetics. 12. 790093–790093. 6 indexed citations
11.
Liang, Shuhang, Hongrui Guo, Kun Ma, et al.. (2021). A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression. Cancer Research. 81(23). 5889–5903. 63 indexed citations
12.
Zhang, Shugeng, Shuhang Liang, Dehai Wu, et al.. (2021). LncRNA coordinates Hippo and mTORC1 pathway activation in cancer. Cell Death and Disease. 12(9). 822–822. 10 indexed citations
13.
Yang, Guangchao, Yuanfei Yao, Dehai Wu, et al.. (2020). Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC). Life Sciences. 263. 118576–118576. 2 indexed citations
14.
15.
Cui, Yifeng, Shuhang Liang, Shugeng Zhang, et al.. (2020). ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway. Journal of Experimental & Clinical Cancer Research. 39(1). 90–90. 32 indexed citations
16.
Yin, Dalong, Shugeng Zhang, Jiabei Wang, et al.. (2020). Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12‐year retrospective study. Liver International. 41(4). 810–818. 54 indexed citations
17.
Luo, Huoling, Dalong Yin, Shugeng Zhang, et al.. (2019). Augmented reality navigation for liver resection with a stereoscopic laparoscope. Computer Methods and Programs in Biomedicine. 187. 105099–105099. 72 indexed citations
18.
Lin, Qiushi, Xuesong Chen, Fanzheng Meng, et al.. (2019). ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Molecular Cancer. 18(1). 156–156. 66 indexed citations
19.
Cui, Yifeng, Dan Sun, Ruipeng Song, et al.. (2019). Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis. Journal of Cellular Physiology. 234(12). 22623–22634. 21 indexed citations
20.
Wang, Jizhou, Zhaoyang Lu, Pei Tian, et al.. (2017). Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease. Scientific Reports. 7(1). 41038–41038. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryota Souzaki Breakdown of academic impact, for papers by Sungwon Lee Breakdown of academic impact, for papers by Jiaxin Li Breakdown of academic impact, for papers by Jingyan Tang Breakdown of academic impact, for papers by Yaling Dou Breakdown of academic impact, for papers by Qi Feng Breakdown of academic impact, for papers by Atsuko Fujihara Breakdown of academic impact, for papers by Hiroto Matsuoka Breakdown of academic impact, for papers by Sae‐Ryung Kang
Rankless by CCL
2026